Menu Search
Equities

Atomo Diagnostics Ltd

AT1:ASX

Atomo Diagnostics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.021
  • Today's Change-0.001 / -4.55%
  • Shares traded394.57k
  • 1 Year change-8.70%
  • Beta1.4204
Data delayed at least 20 minutes, as of Nov 15 2024 03:22 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Atomo Diagnostics Ltd grew revenues 66.63% from 2.54m to 4.24m while net income improved from a loss of 9.96m to a smaller loss of 6.85m.
Gross margin41.48%
Net profit margin-161.56%
Operating margin-161.33%
Return on assets-49.17%
Return on equity-55.06%
Return on investment-54.41%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Atomo Diagnostics Ltd fell by 2.78m. Cash Flow from Financing totalled 1.87m or 44.05% of revenues. In addition the company used 4.69m for operations while cash used for investing totalled 16.08k.
Cash flow per share-0.0082
Price/Cash flow per share--
Book value per share0.0158
Tangible book value per share0.0125
More ▼

Balance sheet in AUDView more

Atomo Diagnostics Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio6.39
Quick ratio4.84
Total debt/total equity0.0084
Total debt/total capital0.0083
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.